Nurses must stay up to date on immunotherapy advancements, since they are the frontline communicators with patients.
Nurses need to have a breadth of knowledge when it comes to immunotherapy, especially as it continues to become more widespread, said Grace Cherry, NP, MSN, RN, a nurse practitioner at the UCLA Melanoma Program.
TRANSCRIPTION
There's a lot of new changes that are going on. Immunotherapy is not just a treatment for melanoma anymore, it's a treatment for many other cancers. Nurses are frontline. They're the ones that give the medication, and our patients are looking to us to explain to them 'how does the drug work' and 'what can I expect?' So I think being up-to-date and being able to explain how they work and having a general knowledge of why we're doing clinical trials would really help us in our role of explaining that to the patients.
UGN-102 Produces Comparable Responses Regardless of Surgery in NMIBC Subset
May 8th 2024Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery.
Verification Nurse Provides ‘Significant Contribution to Patient Safety’ During Chemo Administration
May 1st 2024The role of a verification nurse can lead to several benefits, including the prevention of errors from reaching the patient, decreased workload, and potential cost savings from less drug waste.